Denmark's Novo Nordisk is partnering with biotech company Deep Apple Therapeutics in a deal worth up to $812 million to ...

More Bonds of China Construction Bank Corp. About the China Construction Bank Corp.-Bond (XS3078858670) The China Construction Bank Corp.-Bond has a maturity date of 5/29/2028 I18N_bonds# ...

The French biotech has been evaluating lacutamab in the Tellomak trial of 63 patients with Sézary syndrome (SS), a rare form of the blood cancer, and 107 patients with mycosis fungoides (MF), the ...

247Sports national recruiting analyst Allen Trieu breaks down what three-star Chicago Brother Rice DL King Liggins brings to Illini football. More Live & Upcoming Live CBS Sports Golazo Network ...

More Bonds of Iron Mountain Inc. About the Iron Mountain Inc.-Bond (USU46009AN34) The Iron Mountain Inc.-Bond has a maturity date of 1/15/2033 and offers a coupon of 6.2500%. The payment of the ...

Four-star Clayton (N.C.) defensive lineman Keshawn Stancil is one of the Wolfpack's top targets in the 2026 class, regardless of position. The biggest reason the Pack has a shot to land Stancil is ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said ...

Four-star defensive lineman Anthony Kennedy Jr. backed off his commitment from Missouri on Friday night. The news comes after Mizzou defensive line coach Al Davis announced he was stepping away ...

SINGAPORE - Singapore biotech firm Mirxes launched its initial public offering (IPO) in Hong Kong on May 15, aiming to raise HK$1.09 billion (S$181 million) to support stronger growth in the ...

SHANGHAI, May 15, 2025 /PRNewswire/ -- On May 13, 2025, Viva Biotech successfully held the AIDD platform launch event "Enchantment of Drug Discovery," unveiling the advanced and comprehensive AI ...

As a one-stop drug discovery solution provider, Viva Biotech embraced atomic-level perspective. Dr. Qian emphasized that Viva has over 15 years of experience in structure-based drug discovery ...